z-logo
Premium
Inhibitors of the activity of poly (ADP‐ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts
Author(s) -
Bowes Joanne,
Piper Julie,
Thiemermann Christoph
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702009
Subject(s) - programmed cell death , myocyte , hydrogen peroxide , reactive oxygen species , biochemistry , chemistry , pharmacology , biology , microbiology and biotechnology , apoptosis
Poly (ADP‐ribose) synthetase (PARS) is a nuclear enzyme activated by strand breaks in DNA which are caused by reactive oxygen species (ROS). Inhibitors of PARS activity reduce the degree of reperfusion injury of the heart in vivo and in vitro . Here we investigate the role of PARS in the cell death of human cardiac myoblasts caused by hydrogen peroxide. Exposure of human cardiac myoblasts to hydrogen peroxide caused a time‐ and concentration‐dependent reduction in mitochondrial respiration (cell injury), an increase in cell death (LDH release), as well as an increase in PARS activity. The PARS inhibitors 3‐aminobenzamide (3 m M ), 1,5‐dehydroxyisoquinoline (300 μ M ) or nicotinamide (3 m M ) attenuated the cell injury and death as well as the increase in PARS activity caused by hydrogen peroxide (3 m M ; 4 h for cell injury/death, 60 min for PARS activity) in human cardiac myoblasts. In contrast, the inactive analogues 3‐aminobenzoic acid (3 m M ) or nicotinic acid (3 m M ) were without effect. The iron chelator deferoxamine (1–10 m M ) caused a concentration‐dependent reduction in the cell injury and death caused by hydrogen peroxide in these human cardiac myoblasts. Thus, the cell injury/death caused by hydrogen peroxide in human cardiac myoblasts is secondary to the formation of hydroxyl radicals and due to an increase in PARS activity. We therefore propose that activation of PARS contributes to the cell injury/cell death associated with oxidant stress in the heart.British Journal of Pharmacology (1998) 124 , 1760–1766; doi: 10.1038/sj.bjp.0702009

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here